Ilhem Guernah

1.1k total citations
6 papers, 835 citations indexed

About

Ilhem Guernah is a scholar working on Molecular Biology, Hematology and Infectious Diseases. According to data from OpenAlex, Ilhem Guernah has authored 6 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Hematology and 1 paper in Infectious Diseases. Recurrent topics in Ilhem Guernah's work include Acute Myeloid Leukemia Research (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Retinoids in leukemia and cellular processes (2 papers). Ilhem Guernah is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Retinoids in leukemia and cellular processes (2 papers). Ilhem Guernah collaborates with scholars based in United States, United Kingdom and Canada. Ilhem Guernah's co-authors include Pier Paolo Pandolfi, Julie Teruya‐Feldstein, Carlos Cordon‐Cardo, Taha Merghoub, Takahiro Maeda, Arthur Zelent, Robin M. Hobbs, M. Celeste Simon, Silvia Grisendi and Shahin Rafii and has published in prestigious journals such as Nature, Blood and Clinical Cancer Research.

In The Last Decade

Ilhem Guernah

6 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ilhem Guernah United States	5	690	199	175	144	82	6	835
Marcin M. Gorski Italy	11	887 1.3×	219 1.1×	177 1.0×	74 0.5×	70 0.9×	15	1.1k
Jeannine Diesch Australia	15	591 0.9×	152 0.8×	155 0.9×	99 0.7×	152 1.9×	20	852
Ivan H. Still United States	18	908 1.3×	278 1.4×	188 1.1×	95 0.7×	57 0.7×	27	1.2k
Frederik Roels Germany	10	771 1.1×	326 1.6×	251 1.4×	72 0.5×	87 1.1×	15	1.1k
Deepa Shankar United States	13	649 0.9×	129 0.6×	161 0.9×	93 0.6×	107 1.3×	21	833
Nobuaki Akakura United States	7	328 0.5×	311 1.6×	154 0.9×	63 0.4×	76 0.9×	9	596
Nurten Yigit Belgium	15	577 0.8×	282 1.4×	264 1.5×	63 0.4×	53 0.6×	29	864
Archana Agarwal United States	7	679 1.0×	271 1.4×	154 0.9×	200 1.4×	103 1.3×	18	971
Tetsuharu Shinjyo Japan	10	453 0.7×	88 0.4×	181 1.0×	131 0.9×	157 1.9×	13	703

Countries citing papers authored by Ilhem Guernah

Since Specialization

Citations

This map shows the geographic impact of Ilhem Guernah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilhem Guernah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilhem Guernah more than expected).

Fields of papers citing papers by Ilhem Guernah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilhem Guernah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilhem Guernah. The network helps show where Ilhem Guernah may publish in the future.

Co-authorship network of co-authors of Ilhem Guernah

This figure shows the co-authorship network connecting the top 25 collaborators of Ilhem Guernah. A scholar is included among the top collaborators of Ilhem Guernah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilhem Guernah. Ilhem Guernah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Yin, Yongjun, Craig S. Smith, Qianxu Guo, et al.. (2016). Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody. Disease Models & Mechanisms. 9(5). 563–571. 15 indexed citations

2.

Klimek, Virginia M., P. Maslak, Ilhem Guernah, et al.. (2008). Tolerability, Pharmacodynamics, and Pharmacokinetics Studies of Depsipeptide (Romidepsin) in Patients with Acute Myelogenous Leukemia or Advanced Myelodysplastic Syndromes. Clinical Cancer Research. 14(3). 826–832. 113 indexed citations

3.

Bernardi, Rosa, Ilhem Guernah, David Jin, et al.. (2006). PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR. Nature. 442(7104). 779–785. 314 indexed citations

4.

Maeda, Takahiro, Robin M. Hobbs, Taha Merghoub, et al.. (2005). Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature. 433(7023). 278–285. 307 indexed citations

5.

Maslak, P., Suzanne Chanel, Luis H. Camacho, et al.. (2005). Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome. Leukemia. 20(2). 212–217. 85 indexed citations

6.

Maeda, Takahiro, Robin M. Hobbs, Taha Merghoub, et al.. (2004). POKEMON Is a Proto-Oncogene Which Plays a Key Role in Lymphomagenesis.. Blood. 104(11). 3489–3489. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact